Mabion S.A. | Mutual Funds
Mutual Funds that own Mabion S.A.
Generali OFE
1,470,345
10.72%
370,942
2.12%
12/31/2017
Investor Top 25 Malych Spolek FIO
217,203
1.58%
0
14.03%
12/31/2016
FTIF SICAV - Templeton Eastern Europe Fund
156,250
1.13%
0
1.95%
06/30/2018
Investor Zrownowazony FIO
153,538
1.12%
0
4.33%
12/31/2016
Investor Akcji FIO
119,771
0.87%
20,000
5.73%
06/30/2017
PZU FIO Parasolowy - Energia Medycyna Ekologia
100,151
0.73%
-84,921
3.82%
06/30/2017
MetLife OFE
95,000
0.69%
-25,483
0.09%
12/31/2016
Investor Zabezpieczenia Emerytalnego FIO
65,180
0.48%
0
4.08%
12/31/2016
PZU FIO Parasolowy - Stabilnego Wzrostu MAZUREK
49,808
0.36%
49,808
0.26%
06/30/2017
UniFundusze FIO - UniAkcje Malych i Srednich Spolek
49,716
0.36%
0
2.91%
06/30/2017
| Address |
ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki LD 95
Poland
|
|
Employees
|
- |
| Website |
http://www.mabion.eu |
| Updated |
07/08/2019 |
| Mabion SA is a biotechnology company, which engages in the development and manufacturing of biotech drugs. Its products, which are based on humanized monoclonal antibodies, are used for the treatment of cancer and metabolic diseases. It also involved research in the field of biotechnology. |
